Concepedia
Statistics
Publications
17
Citations
2.7K
H-Index
15
Active since
2015
Affiliations
Gilead Sciences (United States)(Current)
Texas Liver Institute
The University of Texas at San Antonio Health Science Center
Inova Fairfax Hospital
University of California San Diego
C. Stephen Djedjos is an author at Gilead Sciences (United States) specializing in medicine, liver disease, and hepatic fibrosis.
Publications per year
2015–2020
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez Mantry et al. · Hepatology · 2017 · 553 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 389 citations
Medicine, Pathology, Pharmacotherapy +17
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 321 citations
Medicine, Pharmacology, Pharmacotherapy +17
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 266 citations
Medicine, Internal Medicine, Pathology +17
1–5 of 17